Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Sales stay sluggish at Sanofi

November 2, 2007 Sales and Marketing

Sanofi-Aventis outperformed expectations in the third quarter, after a strong performance from its vaccines business and the recovery of blockbuster …
News

NICE rejects arthritis drug Orencia

November 2, 2007 Sales and Marketing NICE

NICE has rejected Orenica, a new treatment for rheumatoid arthritis, saying the drug is not a cost effective option for …
News

Roche maintains sales growth for Q3

November 2, 2007 Sales and Marketing BMS

Third quarter figures show Roche's top-selling products have all posted double-digit advances on the same period in 2006. Growth for …
News

Marketing for maximum ROI impact

November 1, 2007 Sales and Marketing marketing, strategy

From the amount of lip service the pharma industry pays to marketing effectiveness, you might be excused for thinking it …
Feature

Latest news from Datamonitor

October 29, 2007 Sales and Marketing

Oxford BioMedica wins key ruling in patent disputeOxford BioMedica has received a favorable ruling in a US district court for …
News

Dwindling sales mean job cuts at GSK

October 25, 2007 Sales and Marketing Avandia, diabetes

GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …
News

Biotech firms call for reform of European clinical trials

October 25, 2007 Sales and Marketing

Biotech and specialist pharma companies have called for changes to European clinical trials regulations, which they say have imposed a …
News

Redefining pharmaceutical CRM

October 24, 2007 Research and Development, Sales and Marketing CRM, customer relationship management, sales

Fierce generic competition, price containment regulations and poor pipeline productivity are challenges looming over many pharmaceutical companies today. In effect, …
Feature

Novartis changes pharma management after weak third quarter

October 19, 2007 Sales and Marketing Novartis

Novartis has switched the heads of its consumer and pharmaceuticals divisions as part of a wider reorganisation of its pharma …
News

New products behind Lilly growth

October 19, 2007 Sales and Marketing lilly, zyprexa

Sales rose 19% for Lilly in the third quarter of the year, with depression treatment Cymbalta leading the growth in …
News

Pfizer abandons Exubera

October 19, 2007 Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
News

Eucreas a step nearer European approval

October 11, 2007 Sales and Marketing

Novartis' new combination drug, Eucreas, is set for approval following recommendation from Europe's medicines regulator. Eucreas is a single-tablet combination …
News

Wyeth names new chief executive

October 10, 2007 Sales and Marketing Pfizer, Wyeth

Wyeth will begin 2008 with a new leader at the helm. Bernard Poussot will become the company's elected president and …
News

GSK appoints Witty to top job

October 8, 2007 Sales and Marketing

GlaxoSmithKline has named JP Garnier's successor when he steps down as chief executive at the end of May next year.Andrew …
News

FDA rejects painkiller Prexige

October 3, 2007 Sales and Marketing reg, safety

Novartis has received a "not approvable" letter from the FDA for its painkiller Prexige because of concerns about potential liver …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026